Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

902.90
USD
-27.77
(-2.98%)
45.15EPS
16.19P/E
78.42BMarket Cap
Jan 29Next Earn

Regeneron Pharmaceuticals, Inc. Documents

FY2025 · Annual report

Regeneron Pharmaceuticals Inc - Q4 2025 - 10-K · Form 10-K · February 4, 2026 · 147 pages

Read Regeneron Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this annual report
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents